MOG and autoimmune disease: The potential efficacy of this strategy for CNS autoimmune diseases is supported by a proof-of-concept study in a preclinical model, in which transplantation of embryonic stem cell–derived TEPs engineered to express MOG rendered mice resistant to later EAE induction through deletion of MOG-autoreactive T cells and generation of MOG-specific Treg cells [240].